BKIE - ETF AI Analysis
Top Page
BNY Mellon International Equity ETF (BKIE)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent results for investors.
Leading Holdings With Strong Momentum
Several of the largest positions, including ASML and major global banks, have shown strong performance, helping drive the fund’s overall returns.
Very Low Expense Ratio
The fund’s very low fee means investors keep more of the returns compared with many other international equity ETFs.
Broad International Diversification
Exposure across many countries such as Japan, the U.S., the UK, and several European and Asia-Pacific markets helps reduce the impact of problems in any single region.
Balanced Sector Mix
Holdings spread across financials, industrials, health care, consumer sectors, and others provide a mix of cyclical and defensive businesses.
Healthy Asset Size
The ETF’s large asset base suggests it is established and likely to offer good liquidity for everyday investors.
Negative Factors
Recent Short-Term Weakness
The fund has slipped over the past month, showing that returns can be choppy in the short term.
Heavy Country Concentration In Japan
A sizable portion of the portfolio is invested in Japan, which increases the fund’s sensitivity to economic and market conditions there.
Significant Financial Sector Exposure
With a large share of assets in financial companies, the ETF is more exposed to risks from interest rate changes and banking sector stress.
Some Lagging Top Holdings
AstraZeneca and a few other key positions have shown weaker performance, which can drag on overall returns.
Limited Pure Technology Weight
Despite having a standout tech name like ASML, the overall technology sector weight is modest, which may limit upside if global tech stocks outperform.
Foreign Market And Currency Risk
Because the ETF invests heavily outside the U.S., returns can be affected by foreign market swings and currency movements.
BKIE vs. SPDR S&P 500 ETF (SPY)
AUM1.34B
RegionDeveloped Markets
Expense Ratio0.04%
Beta0.75
IssuerBNY Mellon
Inception DateApr 22, 2020
Dividend Yield6.04%
Asset ClassEquity
Index TrackedSolactive GBS Developed Markets ex United States Large & Mid Cap Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume105,276
30 Day Avg. Volume173,612
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.27Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering964
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BKIE Summary
BKIE is the BNY Mellon International Equity ETF, which follows the Solactive GBS Developed Markets ex United States Large & Mid Cap Index. It invests in many companies outside the U.S., across countries like Japan, the UK, Germany, and more, and covers a wide mix of sectors. Well-known holdings include Nestlé and ASML Holding. Someone might invest in BKIE to diversify beyond U.S. stocks and tap into long-term growth in global markets through one simple fund. A key risk is that international stocks can be volatile and the value of the ETF can go up and down with global markets and currencies.
How much will it cost me?The BNY Mellon International Equity ETF (BKIE) has an expense ratio of 0.04%, which means you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking an index rather than relying on active management strategies.
What would affect this ETF?BKIE's focus on developed markets outside the U.S. could benefit from economic recovery in Europe and Asia, as well as growth in sectors like financials and technology, which are heavily weighted in the ETF. However, potential risks include geopolitical tensions, regulatory changes in key regions, or slower-than-expected growth in international markets, which could negatively impact top holdings like ASML and Nestlé. Additionally, currency fluctuations could affect returns for U.S.-based investors.
BKIE Top 10 Holdings
BKIE leans heavily on international heavyweights, with ASML acting as a key engine for long-term gains despite some recent wobbling, thanks to its pivotal role in the global chip supply chain. Financial giants like HSBC, Royal Bank of Canada, and Mitsubishi UFJ are rising, giving the fund a solid backbone of steady, rate-sensitive earnings. On the defensive side, health care names such as Novartis and Roche are holding their ground, while AstraZeneca and Nestlé have been lagging, slightly dragging on returns. Overall, the ETF is broadly diversified across developed markets outside the U.S., with notable tilts toward global banks, pharma leaders, and European industrials.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.51% | $33.50M | €572.60B | 143.26% | 76 Outperform | |
| HSBC Holdings | 1.34% | $17.90M | £262.77B | 60.76% | 80 Outperform | |
| Roche Holding AG | 1.23% | $16.39M | $361.51B | 51.16% | 73 Outperform | |
| Royal Bank Of Canada | 1.11% | $14.75M | $293.84B | 57.98% | 75 Outperform | |
| Novartis AG | 1.08% | $14.40M | CHF230.61B | 32.06% | 80 Outperform | |
| Nestlé SA | 0.97% | $12.90M | CHF208.89B | 10.64% | 71 Outperform | |
| Mitsubishi UFJ Financial Group | 0.95% | $12.64M | ¥39.85T | 52.16% | 76 Outperform | |
| Shell (UK) | 0.94% | $12.55M | £181.34B | 24.71% | 73 Outperform | |
| AstraZeneca | 0.92% | $12.21M | $249.26B | 8.64% | 80 Outperform | |
| Siemens | 0.87% | $11.64M | €213.28B | 22.18% | 74 Outperform |
BKIE Technical Analysis
Positive
―
Price Trends
33.46
Positive
32.77
Positive
31.76
Positive
Market Momentum
0.46
Negative
68.78
Neutral
82.12
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BKIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.97, equal to the 50-day MA of 33.46, and equal to the 200-day MA of 31.76, indicating a bullish trend. The MACD of 0.46 indicates Negative momentum. The RSI at 68.78 is Neutral, neither overbought nor oversold. The STOCH value of 82.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BKIE.
BKIE Peer Comparison
Comparison Results
Performance Comparison
BKIE
BNY Mellon International Equity ETF
35.00
6.84
24.29%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents